DEC 17, 2018 3:11 PM PST

Nanocapsules Improve The Delivery of Antiparasitic Drugs

WRITTEN BY: Nouran Amin

The efficacy of antiparasitic medications highly depends on how they dissolve and are absorbed by the body—limiting the therapeutic potential of traditionally insoluble anti-parasitic drugs.

The chemical structure of Triclabendazole used to treat flatworm infections.

Credit: PLOS

Now, an international team has sought ways to conquer this challenge by developing a new pharmaceutical formula using nanotechnology and nanomedicine approaches. The novel formula will specifically be used to administer the anti-parasitic drug—triclabendazole.

Triclabendazole is used to treat fascioliasis which is an infectious disease caused by flatworms. According to the World Health Organization, an estimated 2.4 million people are infected with fascioliasis. The disease is considered ‘neglected’ because it receives little to no attention and often goes undiagnosed.

Learn more about parasitic infections:

The new formula produces nanocapsules, less than a micron in size, to be loaded with triclabendazole and then bundled together for effective delivery. To bind the drug and coat the oil-core of capsules, researchers used a natural sugar polymer present in the exoskeleton of shellfish as well as the cell walls of some fungi. This polymer is called ‘chitosan’ and will specifically help stabilize the capsule and preserve the drug.

In the nanocapsule from, the drug would be 100 times more soluble than the current tablet form.

"Solubility is a critical challenge for effective anti-parasite medicine. We looked to tackle this problem at the particle level. Triclabendazole taken as a dose made up of billions of tiny capsules would mean the medicine would be more efficiently and quickly absorbed,” explains Professor Goycoolea, from the School of Food Science and Nutrition at the University of Leeds. "Through the use of nanocapsules and nanoemulsions, drug efficiency can be enhanced and new solutions can be considered for the best ways to target medicine delivery."

Source: PLOS ONE

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
OCT 12, 2020
Cancer
Targeting Energy Production in Cells to Fight Leukemia
OCT 12, 2020
Targeting Energy Production in Cells to Fight Leukemia
Much like how a car needs gasoline to run, cells also need a fuel source. Most human cells in the body use oxidative pho ...
NOV 11, 2020
Health & Medicine
A smart path for novel biologics
NOV 11, 2020
A smart path for novel biologics
Introduction  Cell culture is at the heart of the production process for many biopharmaceuticals, but finding the o ...
OCT 21, 2020
Microbiology
The First Treatment for Ebola is Approved by FDA
OCT 21, 2020
The First Treatment for Ebola is Approved by FDA
Ebola virus can pass from animals to humans, and between people. Rarely, it causes outbreaks but when it does, they can ...
OCT 22, 2020
Neuroscience
Placebos Impact Brain Patterns for Emotional Processing
OCT 22, 2020
Placebos Impact Brain Patterns for Emotional Processing
Researchers from Michigan State University have found that placebos reduce markers of emotional distress- even when the ...
NOV 04, 2020
Cancer
Building a New Chemotherapy Drug
NOV 04, 2020
Building a New Chemotherapy Drug
For decades, modern medicine has relied on chemists’ work to produce compounds that could one day be used as a dru ...
NOV 06, 2020
Drug Discovery & Development
New Vaccine Shows Promise for Herpes
NOV 06, 2020
New Vaccine Shows Promise for Herpes
The World Health Organization estimates that over 500 million people have Herpes Simplex Virus Type 2 (HSV-2), a sexuall ...
Loading Comments...